07:33 AM EDT, 03/24/2026 (MT Newswires) -- Philip Wagenheim, Director, on March 20, 2026, sold 65,000 shares in Immunome ( IMNM ) for $1,335,626. Following the Form 4 filing with the SEC, Wagenheim has control over a total of 341,147 common shares of the company, with 341,147 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1472012/000140568426000002/xslF345X05/form4-03242026_010325.xml